Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAvidity Bioscien Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 12/30/2025 | Q4 2025 | N/A | -$1.59 | N/A | N/A | $860.00 K |
| 09/29/2025 | Q3 2025 | N/A | -$1.26 | N/A | N/A | $12.48 M |
| 06/29/2025 | Q2 2025 | N/A | -$1.21 | N/A | N/A | $3.85 M |
| 03/30/2025 | Q1 2025 | N/A | -$0.90 | N/A | N/A | $1.57 M |
| 12/30/2024 | Q4 2024 | N/A | -$0.80 | N/A | N/A | $2.97 M |
| 09/29/2024 | Q3 2024 | N/A | -$0.65 | N/A | N/A | $2.34 M |
| 06/29/2024 | Q2 2024 | N/A | -$0.66 | N/A | N/A | $2.05 M |
| 03/30/2024 | Q1 2024 | N/A | -$0.79 | N/A | N/A | $3.54 M |
| 12/30/2023 | Q4 2023 | N/A | -$0.79 | N/A | N/A | $2.19 M |
| 09/29/2023 | Q3 2023 | N/A | -$0.71 | N/A | N/A | $2.82 M |
| 06/29/2023 | Q2 2023 | N/A | -$0.66 | N/A | N/A | $2.32 M |
| 03/30/2023 | Q1 2023 | N/A | -$0.74 | N/A | N/A | $2.23 M |
| 12/30/2022 | Q4 2022 | N/A | -$0.88 | N/A | N/A | $2.77 M |
| 09/29/2022 | Q3 2022 | N/A | -$0.82 | N/A | N/A | $2.48 M |
| 06/29/2022 | Q2 2022 | N/A | -$0.92 | N/A | N/A | $2.18 M |
| 03/30/2022 | Q1 2022 | N/A | -$0.71 | N/A | N/A | $1.80 M |
| 12/30/2021 | Q4 2021 | N/A | -$0.82 | N/A | N/A | $1.85 M |
| 09/29/2021 | Q3 2021 | N/A | -$0.68 | N/A | N/A | $2.16 M |
| 06/29/2021 | Q2 2021 | N/A | -$0.70 | N/A | N/A | $2.61 M |
| 03/30/2021 | Q1 2021 | N/A | -$0.64 | N/A | N/A | $2.70 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Avidity Bioscien Earnings: FAQ's
The conference call for Avidity Bioscien's latest earnings report can be listened to online.
The conference call transcript for Avidity Bioscien's latest earnings report can be read online.
Avidity Bioscien (:RNAM) has a recorded annual revenue of $18.76 M.
Avidity Bioscien (:RNAM) has a recorded net income of $-684,631,000.Avidity Bioscien has generated $-4.97 earnings per share over the last four quarters.
Avidity Bioscien (:RNAM) has a price-to-earnings ratio of -15.89 and price/earnings-to-growth ratio is 0.84.